Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy launches generic version of AZ drug

Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US
Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US.

Prilosec, a treatment for conditions caused by excess stomach acid, was originally developed and marketed by AZ and experienced sales in the US of $204.2m, according to IMS data cited by Ranbaxy. Under the terms of the new agreement Ranbaxy Pharmaceuticals - a wholly owned subsidiary of India's largest pharma company, Ranbaxy Laboratories - will begin manufacturing the drug using its generic name, omeprazole.

"We welcome the opportunity to market an authorised generic of omeprazole 40mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under the Ranbaxy label," said Jim Meehan, vice-president of sales and distribution for RPI.

RPI is based in Florida and markets products to the US healthcare system.

28th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics